Dr Ismail Ben Ayed

Under his leadership, DIAGNOS has reached major technological milestones, continuously raising the accuracy of its machine learning algorithms. A true driver of the company’s transformation, Dr. Ben Ayed has successfully integrated the latest advances in artificial intelligence into the demanding medical device sector. His ability to lead large-scale research initiatives, notably through strategic collaborations between academia and industry, gives DIAGNOS the agility needed to keep pace with disruptive innovation.

His unique expertise allows him to turn every pixel into usable medical insight, positioning DIAGNOS as a technological sentinel at the forefront of global innovation. By bridging fundamental research and the critical needs of clinicians, he oversees the development of solutions capable of detecting not only retinal disease, but also early signals of other complex pathological conditions. His vision ensures that the company remains a leader in responsible artificial intelligence, where computing power serves clinical safety and data integrity.

Dr. Ben Ayed ensures that scientific excellence translates into tangible value for shareholders and patients alike. His research discipline is aimed at converting algorithmic complexity into tools verified through real-world practice, thereby protecting users’ health trajectories around the world. For investors, his technological leadership is a guarantee of long-term competitiveness and resilience; for healthcare professionals, it ensures access to advanced, rigorous, and ethical technology.